Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Clinical Imbalances

Hormonal

Immune and inflammation

Structural Integrity and Musculoskeletal

Modifiable Lifestyle Factors

Diet

Laboratory Testing

Blood

Urine

Text Availability

Abstract

287

Full text

213

Free full text

103

Publication Types

Journal Article

287

Research Support, Non-U.S. Gov't

151

Randomized Controlled Trial

151

Clinical Trial

Review

Research Support, N.I.H., Extramural

Comparative Study

Controlled Clinical Trial

Research Support, U.S. Gov't, P.H.S.

Multicenter Study

Meta-Analysis

Systematic Review

Research Support, U.S. Gov't, Non-P.H.S.

Observational Study

Letter

Clinical Trial, Phase III

Research Support, N.I.H., Intramural

Clinical Trial, Phase II

Comment

Evaluation Study

Scoping Review

Twin Study

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Plasminogen Activator Inhibitor 1""[mesh_terms]

289 Results

Searching titles within these results

Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk.

Tiny Hoekstra, Johanna M Geleijnse, Evert G Schouten, Cees Kluft

Thrombosis and haemostasis 2004;91(5):861-72

Full Text

Abstract

Hemostasis alterations in metabolic syndrome (review).

Marcelo Alarcón, Rodrigo Moore-Carrasco, Josep M Argilés, Iván Palomo

International journal of molecular medicine 2007;18(5):969-74

Full Text

Abstract

The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis.

Georgios K Nikolopoulos, Pantelis G Bagos, Iraklis Tsangaris, Chrissa G Tsiara, Petros Kopterides, Aristides Vaiopoulos, Violetta Kapsimali, Stefanos Bonovas, Argirios E Tsantes

Clinical chemistry and laboratory medicine 2015;52(7):937-50

Free Full Text

Abstract

Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1).

Gael B Morrow, Nicola J Mutch

Seminars in thrombosis and hemostasis 2023;49(3):305-313

Full Text

Abstract

Postprandial triglycerides and blood coagulation.

A Silveira

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2001;109(4):S527-32

Full Text

Abstract

The plasma levels of prostanoids and plasminogen activator inhibitor-1 in primary and secondary thrombocytosis.

A Birdane, I C Haznedaroğlu, N Bavbek, A Koşar, Y Büyükaşik, O Ozcebe, S Kirazli, S V Dündar

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2005;11(2):197-201

Free Full Text

Abstract

Improved fibrinolytic activity during exercise may be an effect of the adipocyte-derived hormones leptin and adiponectin.

Maria Eriksson, Owe Johnson, Kurt Boman, Göran Hallmans, Gideon Hellsten, Torbjörn K Nilsson, Stefan Söderberg

Thrombosis research 2008;122(5):701-8

Full Text

Abstract

NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH.

Jonathan G Stine, Ian R Schreibman, Alison J Faust, Jessica Dahmus, Benjamin Stern, Christopher Soriano, Gloriany Rivas, Breianna Hummer, Scot R Kimball, Nate R Geyer, Vernon M Chinchilli, Rohit Loomba, Kathryn Schmitz, Christopher Sciamanna

Hepatology (Baltimore, Md.) 2022;76(1):172-185

Free Full Text

Abstract